The roles of TLRs, RLRs and NLRs in pathogen recognition

International Immunology

Volumn 21, Issue 4, 2009, Pages 317-337

  Kawai, Taro ^a,b   Akira, Shizuo ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Innate immunity; NOD like receptor; RIG I like receptor; Signal transduction; Toll like receptor

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CELL DNA; CELL PROTEIN; CRYOPYRIN; DECTIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEIC ACID; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR; PROTEIN IPAF; RETINOIC ACID INDUCIBLE PROTEIN I LIKE RECEPTOR; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; AUTOIMMUNITY; CELL ORGANELLE; CELL SURFACE; CYTOPLASM; ENDOSOME; ENZYME ACTIVATION; GENE EXPRESSION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INFECTION; INFLAMMASOME; INNATE IMMUNITY; LYSOSOME; MOLECULAR PHYLOGENY; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; AUTOIMMUNITY; CARD SIGNALING ADAPTOR PROTEINS; CARRIER PROTEINS; HUMANS; IMMUNITY, INNATE; INFECTION; NOD1 SIGNALING ADAPTOR PROTEIN; NOD2 SIGNALING ADAPTOR PROTEIN; RECEPTORS, PATTERN RECOGNITION; TOLL-LIKE RECEPTORS;

EID: 63649108380     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxp017     Document Type: Review

References (230)

1. Hoffmann, J. A. 2003. The immune response of Drosophila. Nature 426:33.
2. Akira, S., Uematsu, S. and Takeuchi, O. 2006. Pathogen recognition and innate immunity. Cell 124:783.
3. Beutler, B., Eidenschenk, C., Crozat, K. et al. 2007. Genetic analysis of resistance to viral infection. Nat. Rev. Immunol. 7:753.
4. Medzhitov, R. 2007. Recognition of microorganisms and activation of the immune response. Nature 449:819.
5. Janeway, C. A., Jr, 1989. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54:1.
6. Lemaitre, B., Nicolas, E., Michaut, L., Reichhart, J. M. and Hoffmann, J. A. 1996. The dorsoventral regulatory gene cassette spatzle/Toll/ cactus controls the potent antifungal response in Drosophila adults. Cell 86:973.
7. Medzhitov, R., Preston-Hurlburt, P. and Janeway, C. A., Jr, 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394.
8. Poltorak, A., He, X., Smirnova, I. et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 282:2085.
9. Hoshino, K., Takeuchi, O., Kawai, T. et al. 1999. Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the Lps gene product. J. Immunol. 162:3749.
10. Yoneyama, M. and Fujita, T. 2008. Structural mechanism of RNA recognition by the RIG-I-like receptors. Immunity 29:178.
11. Ting, J. P., Lovering, R. C., Alnemri, E. S. et al. 2008. The NLR gene family: A standard nomenclature. Immunity 28:285.
12. Inohara, N., Chamaillard, McDonald, C. and Nuñez, G. 2005. NOD-LRR proteins: Role in host-microbial interactions and inflammatory disease. Annu. Rev. Biochem. 74:355.
13. Meylan, E., Tschopp, J. and Karin, M. 2006. Intracellular pattern recognition receptors in the host response. Nature 442:39.
14. Fritz, J. H., Ferrero, R. L., Philpott, D. J. and Girardin, S. E. 2006. Nod-like proteins in immunity, inflammation and disease. Nat. Immunol. 7:1250.
15. Ting, J. P., Kastner, D. L. and Hoffman, H. M. 2006. CATERPILLERs, pyrin and hereditary immunological disorders. Nat. Rev. Immunol. 6:183.
16. Kanneganti, T. D., Lamkanfi, M. and Núñez, G. 2007. Intracellular NOD-like receptors in host defense and disease. Immunity 27:549.
17. Yu, H. B. and Finlay, B. B. 2008. The Caspase-1 inflammasome: A pilot of innate immune responses. Cell Host Microbe 4:198.
18. Ishii, K. J. and Akira, S. 2006. Innate immune recognition of, and regulation by, DNA. Trends Immunol. 27:525.
19. Stetson, D. B. and Medzhitov, R. 2006. Type I interferons in host defense. Immunity 25:373.
20. Jin, M. S. and Lee, J. O. 2008. Structures of the toll-like receptor family and its ligand complexes. Immunity 29:182.
21. Choe, J., Kelker, M. S. and Wilson, I. A. 2005. Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science 309:581.
22. Jin, M. S., Kim, S. E., Heo, J. Y. et al. 2007. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 130:1071.
23. Kim, H. M., Park, B. S., Kim, J. I. et al. 2007. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130:906.
24. Ohto, U., Fukase, K., Miyake, K. and Satow, Y. 2007. Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa. Science 316:1632.
25. Miyake, K. 2007. Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors. Semin. Immunol. 19:3.
26. Jiang, Z., Georgel, P., Du, X. et al. 2005. CD14 is required for MyD88-independent LPS signaling. Nat. Immunol. 6:565.
27. Hoebe, K., Georgel, P., Rutschmann, S. et al. 2005. CD36 is a sensor of diacylglycerides. Nature 433:523.
28. Gantner, B. N., Simmons, R. M., Canavera, S. J., Akira, S. and Underhill, D. M. 2003. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J. Exp. Med. 197:1107.
29. Hayashi, F., Smith, K. D., Ozinsky, A. et al. 2001. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410:1099.
30. Uematsu, S., Jang, M. H., Chevrier, N. et al. 2006. Detection of pathogenic intestinal bacteria by Toll-like receptor 5 on intestinal CD11c+ lamina propria cells. Nat. Immunol. 7:868.
31. Uematsu, S., Fujimoto, K., Jang, M. H. et al. 2008. Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. Nat. Immunol. 9:769.
32. Zhang, D., Zhang, G., Hayden, M. S. et al. 2004. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 303:1522.
33. Plattner, F., Yarovinsky, F., Romero, S. et al. 2008. Toxoplasma profilin is essential for host cell invasion and TLR11-dependent induction of an interleukin-12 response. Cell Host Microbe 3:77.
34. Yarovinsky, F., Zhang, D., Andersen, J. F. et al. 2005. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308:1626.
35. Latz, E., Schoenemeyer, A., Visintin, A. et al. 2004. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat. Immunol. 5:190.
36. Nishiya, T., Kajita, E., Miwa, S. and Defranco, A. L. 2005. TLR3 and TLR7 are targeted to the same intracellular compartments by distinct regulatory elements. J. Biol. Chem. 280:37107.
37. Alexopoulou, L., Holt, A. C., Medzhitov, R. and Flavell, R. A. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413:732.
38. Wang, T., Town, T., Alexopoulou, L., Anderson, J. F., Fikrig, E. and Flavell, R. A. 2004. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 10:1366.
39. Tabeta, K., Georgel, P., Janssen, E. et al. 2004. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl Acad. Sci. USA. 101:3516.
40. Zhang, S. Y., Jouanguy, E., Ugolini, S. et al. 2007. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317:1522.
41. Edelmann, K. H., Richardson-Burns, S., Alexopoulou, L., Tyler, K. L., Flavell, R. A. and Oldstone, M. B. 2004. Does Toll-like receptor 3 play a biological role in virus infections? Virology. 322:231.
42. Le Goffic, R., Balloy, V., Lagranderie, M. et al. 2006. Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog. 2:e53.
43. Schulz, O., Diebold, S. S., Chen, M. et al. 2005. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 433:887.
44. Kleinman, M. E., Yamada, K., Takeda, A. et al. 2008. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 452:591.
45. Hemmi, H., Kaisho, T., Takeuchi, O. et al. 2002. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 3:196.
46. Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., Reis, E. and Sousa, C. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303: 1529.
47. Heil, F., Hemmi, H., Hochrein, H. et al. 2004. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303:1526.
48. Gilliet, M., Cao, W. and Liu, Y. J. 2008. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 8:594.
49. Lund, J. M., Alexopoulou, L., Sato, A. et al. 2004. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl Acad. Sci. USA. 101:5598.
50. Hemmi, H., Takeuchi, O., Kawai, T. et al. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408:740.
51. Haas, T., Metzger, J., Schmitz, F. et al. 2008. The DNA sugar backbone 2′ deoxyribose determines toll-like receptor 9 activation. Immunity 28:315.
52. Lund, J., Sato, A., Akira, S., Medzhitov, R. and Iwasaki, A. 2003. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198:513.
53. Krug, A., French, A. R., Barchet, W. et al. 2004. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21:107.
54. Krug, A., Luker, G. D., Barchet, W., Leb, D. A., Akira, S. and Colonna, M. 2004. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 103:1433.
55. Coban, C., Ishii, K. J., Kawai, T. et al. 2005. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J. Exp. Med. 201:19.
56. Pichyangkul, S., Yongvanitchit, K., Kum-arb, U. et al. 2004. Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway. J. Immunol. 172:4926.
57. Parroche, P., Lauw, F. N., Goutagny, N. et al. 2007. Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc. Natl Acad. Sci. USA 104:1919.
58. Hisaeda, H., Tetsutani, K., Imai, T. et al. 2008. Malaria parasites require TLR9 signaling for immune evasion by activating regulatory T cells. J. Immunol. 180:2496.
59. Barton, G. M., Kagan, J. C. and Medzhitov, R. 2006. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat. Immunol. 7:49.
60. Tabeta, K., Hoebe, K., Janssen, E. M. et al. 2006. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat. Immunol. 7:156.
61. Kim, Y. M., Brinkmann, M. M., Paquet, M. E. and Ploegh, H. L. 2008. UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature 452:234.
62. Brinkmann, M. M., Spooner, E., Hoebe, K., Beutler, B., Ploegh, H. L. and Kim, Y. M. 2007. The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling. J. Cell Biol. 177:265.
63. Ewald, S. E., Lee, & L., Lau, L. et al. 2008. The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor. Nature 456:658.
64. Park, B., Brinkmann, M. M., Spooner, E., Lee, C. C., Kim, Y. M. and Ploegh, H. L. 2008. Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9. Nat. Immunol. 9:1407.
65. Lee, H. K., Lund, J. M., Ramanathan, B., Mizushima, N. and Iwasaki, A. 2007. Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 315:1398.
66. Sanjuan, M. A., Dillon, C. P., Tait, S. W. et al. 2007. Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature 450:1253.
67. Jounai, N., Takeshita, F., Kobiyama, K. et al. 2007. The Atg5 Atg12 conjuqate associates with innate antiviral immune responses. Proc. Natl Acad Sci. USA 104:14050.
68. Kawai, T. and Akira, S. 2006. Innate immune recognition of viral infection. Nat. Immunol. 7:131.
69. Cui S, Eisenächer, K., Kirchhofer, A. et al. 2008. The C-terminal regulatory domain is the RNA 5′-triphosphale sensor of RIG-I. Mol. Cell 29:169.
70. Takahasi, K., Yoneyama, M., Nishihori, T. et al. 2008. Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol. Cell 29:428.
71. Kato, H., Sato, S., Yoneyama, M. et al. 2005. Cell type specific involvment of RIG-I in antiviral response. Immunity 23:19.
72. Kato, H., Takeuchi, O., Sato, S. et al. 2006. Differential role of MDA5 and RIG-I in t1he recognition of RNA viruses. Nature 441:101.
73. Hornung, V., Ellegast, J., Kim, S. et al. 2006. 5′-Triphosphate RNA is the ligand for RIG-I. Science 314:994.
74. Pichlmair, A., Schulz, O., Tan, C. P. et al. 2006. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314:997.
75. Saito, T., Owen, D. M., Jiang, F., Marcotrigiano, J. and Gale, M. J. 2008. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454:523.
76. Marques, J. T., Devosse, T., Wang, D. et al. 2006. A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat. Biotechnol. 24:559.
77. Kato, H., Takeuchi, O., Mikamo-Satoh, E. et al. 2008. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J. Exp. Med. 205:1601.
78. Venkataraman, T., Valdes, M., Elsby, R. et al. 2007. Loss of DExD/ H box RNA helicase LGP2 manifests disparate antiviral responses. J. Immunol. 178:6444.
79. Ishii, K. J., Coban, C., Kato, H. et al. 2006. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat. Immunol. 7:40.
80. Stetson, D. B. and Medzhitov, R. 2006. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 24:93.
81. Kawai, T., Sato, S., Ishii, K. J. et al. 2004. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat. Immunol. 5:1061.
82. Takaoka, A., Wang, Z., Choi, M. K. et al. 2007. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448:501.
83. Ishii, K. J., Kawagoe, T., Koyama, S. et al. 2008. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature 451:725.
84. Ishikawa, H. and Barber, G. N. 2008. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455:674.
85. Jones, J. D. and Dang, J. L. 2006. The plant immune system. Nature 444:323.
86. Mayor, A., Martinon, F., De Smedt, T., Pétrilli, V. and Tschopp, J. 2007. A crucial function of SGT1 and HSP90 in inflammasome activity links mammalian and plant innate immune responses. Nat. Immunol. 8:497.
87. de Silva Correria, J., Miranda, Y., Leonard, L. and Ulevitch, R. 2007. SGT1 is essential for NOD1 activation. Proc. Natl Acad. Sci. USA 104:6764.
88. Chamaillard, M., Hashimoto, M., Horie, Y. et al. 2003. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol. 4:702.
89. Girardin, S. E., Boneca, I. G., Carneiro, L. A. et al. 2003. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300:1584.
90. Girardin, S. E., Boneca, I. G., Viala, J. et al. 2003. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278:8869.
91. Inohara, N., Ogura, Y., Fontalba, A. et al. 2003. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Biol. Chem. 278:5509.
92. Viala, J., Chaput, C., Boneca, I. G. et al. 2004. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol. 5:1166.
93. Kobayashi, K. S., Chamaillard, M., Ogura, Y. et al. 2005. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307:731.
94. Mariathasan, S., Weiss, D. S., Newton, K. et al. 2006. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440:228.
95. Kanneganti, T. D., Body-Malapel, M., Amer, A. et al. 2006. Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J. Biol. Chem. 281:36560.
96. Kanneganti, T. D., Ozoren, N., Body-Malapel, M. et al. 2006. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 440:233.
97. Sutterwala, F. S., Ogura, Y., Szczepanik, M. et al. 2006. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24:317.
98. Atarashi, K., Nishimura, J., Shima, T. et al. 2008. ATP drives lamina propria T(H)17 cell differentiation. Nature 455:808.
99. Piccini, A., Carta, S., Tassi, S., Lasiglié, D., Fossati, G. and Rubartelli, A. 2008. ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way. Proc. Natl Acad. Sci. USA. 105:8067.
100. Pelegrin, P. and Surprenant, A. 2007. Pannexin-1 couples to maitotoxin- and nigericin-induced interleukin-1beta release through a dye uptake-independent pathway. J. Biol. Chem. 282:2386.
101. Pelegrin, P. and Surprenant, A. 2006. Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J. 25:5071.
102. Kanneganti, T. D., Lamkanfi, M., Kim, Y. G. et al. 2007. Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. Immunity 26:433.
103. Franchi, L., Kanneganti, T. D., Dubyak, G. R. and Núñez, G. 2007. Differential requirement of P2X7 receptor and intracellular K+ for caspase-1 activation induced by intracellular and extracellular bacteria. J. Biol. Chem. 282:18810.
104. Petrilli, V., Papin, S., Dostert, C., Mayor, A., Martinon, F. and Tschopp, J. 2007. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ. 13:1835.
105. Gurcel, L., Abrami, L., Girardin, S., Tschopp, J. and van der Goot, F. G. 2006. Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival. Cell 126:1135.
106. Martinon, F., Agostini, L., Meylan, E. and Tschopp, J. 2004. Identification of bacterial muramyl dipeptide as activator of the NALP3/ cryopyrin inflammasome. Curr. Biol. 14:1929.
107. Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. and Tschopp, J. 2006. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237.
108. Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T. and Tschopp, J. 2008. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320:674.
109. Eisenbarth, S. C., Colegio, O. R., O'Connor, W., Sutterwala, F. S. and Flavell, R. A. 2008. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453:1122.
110. Hornung, V., Bauernfeind, F., Halle, A. et al. 2008. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9:847.
111. Muruve, D. A., Pétrilli, V., Zaiss, A. K. et al. 2008. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452:103.
112. Halle, A., Hornung, V., Petzold, G. C. et al. 2008. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol. 9:857.
113. Feldmeyer, L., Keller, M., Niklaus, G., Hohl, D., Werner, S. and Beer, H. D. 2007. The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes. Curr. Biol. 17:1140.
114. Cassel, S. L., Eisenbarth, S. C., Iyer, S. S. et al. 2008. The Nalp3 inflammasome is essential for the development of silicosis. Proc. Natl Acad. Sci. USA. 105:9035.
115. Boyden, E. D. and Dietrich, W. F. 2006. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat. Genet. 38:240.
116. Hsu, L. C., Ali, S. R., McGillivray, S. et al. 2008. A NOD2-NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptide. Proc. Natl Acad. Sci. USA. 105:7803.
117. Bruey, J. M., Bruey-Sedano, N., Luciano, F. et al. 2007. Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1. Cell 129:45.
118. Franchi, L., Amer, A., Body-Malapel, M. et al. 2006. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat. Immunol. 7:576.
119. Miao, E. A., Alpuche-Aranda, C. M., Dors, M. et al. 2006. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat. Immunol. 7:569.
120. Amer, A., Franchi, L., Kanneganti, T. D. et al. 2006. Regulation of Legionella phagosome maturation and infection through flagellin and host Ipaf. J. Biol. Chem. 281:35217.
121. Ren, T., Zamboni, D. S., Roy, C. R., Dietrich, W. F. and Vance, R. E. 2006. Flagellin-deficient Legionella mutants evade caspase-1-and Naip5-mediated macrophage immunity. PLoS Pathog. 2:e18.
122. Zamboni, D. S., Kobayashi, K. S., Kohlsdorf, T. et al. 2006. The Birc1e cytosolic pattern-recognition receptor contributes to the detection and control of Legionella pneumophila infection. Nat. Immunol. 7:318.
123. Molofsky, A. B., Byrne, B. G., Whitfield, N. N. et al. 2006. Cytosolic recognition of flagellin by mouse macrophages restricts Legionella pneumophila infection. J. Exp. Med. 203:1093.
124. Lightfield, K. L., Persson, J., Brubaker, S. W. et al. 2008. Critical function for Naip5 in inflammasome activation by a conserved carboxy-terminal domain of flagellin. Nat. Immunol. 9:1171.
125. Shaw, M. H., Reimer, T., Kim, Y. G. and Nuñez, G. 2008. NOD-like receptors (NLRs): bona fide intracellular microbial sensors. Curr. Opin. Immunol. 20:377.
126. Goto, A., Matsushita, K., Gesellchen, V. et al. 2008. Akirins are highly conserved nuclear proteins required for NF-kappaB-dependent gene expression in drosophila and mice. Nat. Immunol. 9:97.
127. Yamamoto, M., Yamazaki, S., Uematsu, S. et al. 2004. Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta. Nature 430:218.
128. Kawai, T. and Akira, S. 2007. TLR signaling. Semin. Immunol. 19:24.
129. Kagan, J. C. and Medzhitov, R. 2006. Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 125:943.
130. Kagan, J. C., Su, T., Horng, T., Chow, A., Akira, S. and Medzhitov, R. 2008. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat. Immunol. 9:361.
131. Tanimura, N., Saitoh, S., Matsumoto, F., Akashi-Takamura, S. and Miyake, K. 2008. Roles for LPS-dependent interaction and relocation of TLR4 and TRAM in TRIF-signaling. Biochem. Biophys. Res. Commun. 368:94.
132. McGettrick, A. F., Brint, E. K., Palsson-McDermott, E. M. et al. 2006. Trif-related adapter molecule is phosphorylated by PKC{epsilon} during Toll-like receptor 4 signaling. Proc. Natl Acad. Sci. USA. 103:9196.
133. Hacker, H., Redecke, V., Blagoev, B. et al. 2006. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439:204.
134. Oganesyan, G., Saha, S. K., Guo, B. et al. 2006. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 439:208.
135. Saha, S. K., Pietras, E. M., He, J. Q. et al. 2006. Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. EMBO J. 25:3257.
136. Kawagoe, T., Sato, S., Matsushita, K. et al. 2008. Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2. Nat. Immunol. 9:684.
137. Yamamoto, M., Okamoto, T., Takeda, K. et al. 2006. Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling. Nat. Immunol. 7:962.
138. Sato, S., Sanjo, H., Takeda, K. et al. 2005. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 6:1087.
139. Shim, J. H., Xiao, C., Paschal, A. E. et al. 2005. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 19:2668.
140. Ermolaeva, M. A., Michallet, M. C., Papadopoulou, N. et al. 2008. Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses. Nat. Immunol. 9:1037.
141. Pobezinskaya, Y. L., Kim, Y. S., Choksi, S. et al. 2008. The function of TRADD in signaling through tumor necrosis factor receptor 1 and TRIF-dependent Toll-like receptors. Nat. Immunol. 9:1047.
142. Sharma, S., tenOever, B. R., Grandvaux, N., Zhou, G. P., Lin, R. and Hiscott, J. 2003. Triggering the interferon antiviral response through an IKK-related pathway. Science 300:1148.
143. Fitzgerald, K. A., McWhirter, S. M., Faia, K. L. et al. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4:491.
144. Honda, K., Yanai, H., Negishi, H. et al. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434:772.
145. Honda, K., Yanai, H., Mizutani, T. et al. 2004. Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc. Natl Acad. Sci. USA 101:15416.
146. Uematsu, S., Sato, S., Yamamoto, M. et al. 2005. Interleukin-1 receptor-associated kinase-1 (IRAK-1) plays an essential role for TLR7- and TLR9-mediated interferon-a_induction. J. Exp. Med. 201:915.
147. Hoshino, K., Sugiyama, T., Matsumoto, M. et al. 2006. IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9. Nature 440:949.
148. Shinohara, M. L., Lu, L., Bu, J. et al. 2006. Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells. Nat. Immunol. 7:498.
149. Guiducci, C., Ghirelli, C., Marloie-Provost, M. A. et al. 2008. PI3K is critical for the nuclear translocation of IRF-7 and type I IFN production by human plasmacytoid predendritic cells in response to TLR activation. J. Exp. Med. 205:315.
150. Honda, K., Ohba, Y., Yanai, H. et al. 2005. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434:1035.
151. Takaoka, A., Yanai, H., Kondo, S. et al. 2005. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434:243.
152. Negishi, H., Fujita, Y., Yanai, H. et al. 2006. Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program. Proc. Natl Acad. Sci. USA. 103:15136.
153. Schmitz, F., Heit, A., Guggemoos, S. et al. 2007. Interferon-regulatory-factor 1 controls Toll-like receptor 9-mediated IFN-beta production in myeloid dendritic cells. Eur. J. Immunol. 37:315.
154. Tsujimura, H., Tamura, T., Kong, H. J. et al. 2004. Toll-like receptor 9 signaling activates NF-kappaB through IFN regulatory factor-8/ IFN consensus sequence binding protein in dendritic cells. J. Immunol. 172:6820.
155. Tailor, P., Tamura, T., Kong, H. J. et al. 2007. The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8. Immunity 27:228.
156. Kong, H. J., Anderson, D. E., Lee, C. H. et al. 2007. Autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages. J. Immunol. 179:26.
157. Kawai, T., Takahashi, K., Sato, S. et al. 2005. IPS-1; an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6:981.
158. Seth, R. B., Sun, L., Ea, C. K. and Chen, Z. J. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF3. Cell 122:669.
159. Meylan, E., Curran, J., Hofmann, K. et al. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167.
160. Xu, L. G., Wang, Y. Y., Han, K. J., Li, L. Y., Zhai, Z. and Shu, H. B. 2005. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19:727.
161. Michallet, M. C., Meylan, E., Ermolaeva, M. A. et al. 2008. TRADD protein is an essential component of the RIG-like helicase antiviral pathway. Immunity 28:651.
162. Takahashi, K., Kawai, T., Kumar, H., Sato, S., Yonehara, S. and Akira, S. 2006. Roles of Caspase-8 and Caspase-10 in antiviral innate immune responses. J. Immunol. 176:4520.
163. Schroder, M., Baran, M. and Bowie, A. G. 2008. Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation. EMBO J. 27:2147.
164. Soulat, D., Bürckstümmer, T., Westermayer, S. et al. 2008. The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response. EMBO J. 27:2135.
165. Balachandran, S., Thomas, E. and Barber, G. N. 2004. A FADD-dependent innate immune mechanism in mammalian cells. Nature 432:401.
166. Zhong, B., Yang, Y., Li, S. et al. 2008. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 29:538.
167. Gack, M. U., Shin, Y. C., Joo, C. H. et al. 2007. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446:916.
168. Underhill, D. M., Rossnagle, E., Lowell, C. A. and Simmons, R. M. 2005. Dectin-1 activates Syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production. Blood 206: 2543.
169. Rogers, N. C., Slack, E. C., Edwards, A. D. et al. 2005. Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity 22:507.
170. Gross, O., Gewies, A., Finger, K. et al. 2006. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 442:651.
171. Hara, H., Ishihara, C., Takeuchi, A. et al. 2007. The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors. Nat. Immunol. 8:619.
172. Hsu, Y. M., Zhang, Y., You, Y. et al. 2007. The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens. Nat. Immunol. 8:198.
173. LeibundGut-Landmann, S., Gross, O., Robinson, M. J. et al. 2007. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 8:630.
174. Saijo, S., Fujikado, N., Furuta, T. et al. 2007. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat. Immunol. 8:39.
175. Taylor, P. R., Tsoni, S. V., Willment, J. A. et al. 2007. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat. Immunol. 8:31.
176. Park, J. H., Kim, Y. G., McDonald, C. et al. 2007. RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs. J. Immunol. 178:2380.
177. Hasegawa, M., Fujimoto, Y., Lucas, P. C. et al. 2008. A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation. EMBO J. 27:373.
178. Hitotsumatsu, O., Ahmad, R. C., Tavares, R. et al. 2008. The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals. Immunity 28:381.
179. O'Neill, L. A. 2008. When signaling pathways collide: Positive and negative regulation of toll-like receptor signal transduction. Immunity 29:12.
180. An, H., Hou, J., Zhou, J. et al. 2008. Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1. Nat. Immunol. 9:542.
181. An, H., Zhao, W., Hou, J. et al. 2006. SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production. Immunity 25:919.
182. Arimoto, K., Takahashi, H., Hishiki, T., Konishi, H., Fujita, T. and Shimotohno, K. 2007. Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. Proc. Natl Acad. Sci. USA. 104:7500.
183. Diao, F., Li, S., Tian, Y. et al. 2007. Negative regulation of MDA5-but not RIG-I-mediated innate antiviral signaling by the dihydroxyacetone kinase. Proc. Natl Acad. Sci. USA. 104:11706.
184. Kayagaki, N., Phung, Q., Chan, S. et al. 2007. DUBA: A deubiquitinase that regulates type I interferon production. Science 318:1628.
185. Moore, C. B., Bergstralh, D. T., Duncan, J. A. et al. 2008. NLRX1 is a regulator of mitochondrial antiviral immunity. Nature 451:573.
186. Tattoli, I., Carneiro, L. A., Jéhanno, M. et al. 2008. NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-kappaB and JNK pathways by inducing reactive oxygen species production. EMBO Rep. 9:293.
187. Hampe, J., Franke, A., Rosenstiel, P. et al. 2007. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet. 39:207.
188. Saitoh, T., Fujita, N., Jang, M. H. et al. 2008. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 456:264.
189. Cadwell, K., Liu, J. Y., Brown, S. L. et al. 2008. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 456:259.
190. Higgs, R., Ní Gabhann, J., Ben Larbi, N., Breen, E. P., Fitzgerald, K. A. and Jefferies, C. A. 2008. The E3 ubiquitin ligase Ro52 negatively regulates IFN-beta production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3. J. Immunol. 181:1780.
191. Tanaka, T., Grusby, M. J. and Kaisho, T. 2007. PDLIM2-mediated termination of transcription factor NF-kappaB activation by intranuclear sequestration and degradation of the p65 subunit. Nat. Immunol. 8:584.
192. Ananieva, O., Darragh, J., Johansen, C. et al. 2008. The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling. Nat. Immunol. 9:1028.
193. Rothlin, C. V., Ghosh, S., Zuniga, E. I., Oldstone, M. B. and Lemke, G. 2007. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131:1124.
194. Jung, A., Kato, H., Kumagai, Y. et al. 2008. Lymphocytoid choriomeningitis virus activates plasmacytoid dendritic cells and induces a cytotoxic T-cell response via MyD88. J. Virol. 82:196.
195. Koyama, S., Ishii, K. J., Kumar, H. et al. 2007. Differential role of TLR- and RLR-signaling in the immune responses to influenza A virus
196. Kumagai, Y., Takeuchi, O., Kato, H. et al. 2007. Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses. Immunity 27:240.
197. Bhoj, V. G., Sun, Q., Bhoj, E. J. et al. 2008. MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus. Proc. Natl Acad. Sci. USA 105:14046.
198. Kumar, H., Koyama, S., Ishii, K. J., Kawai, T. and Akira, S. 2008. Cooperation of IPS-1- and TRIF-dependent pathways in poly IC-enhanced antibody production and cytotoxic T cell responses. J. Immunol. 180:683.
199. Akazawa, T., Ebihara, T., Okuno, M. et al. 2007. Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells. Proc. Natl Acad. Sci. USA. 104:252.
200. Fritz, J. H., Le Bourhis, L., Sellge, G. et al. 2007. Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity. Immunity 26:445.
201. van Beelen, A. J., Zelinkova, Z., Taanman-Kueter, E. W. et al. 2007. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 27:660.
202. Li, H., Willingham, S. B., Ting, J. P. and Re, F. 2008. Inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J. Immunol. 181:17.
203. Kool, M., Pétrilli, V., De Smedt, T. et al. 2008. Alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J. Immunol. 181:3755.
204. Franchi, L. and Núñez, G. 2008. The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity. Eur. J. Immunol. 38:2085.
205. Baccala, R., Hoebe, K., Kono, D. H., Beutler, B. and Theofilopoulos, A. N. 2007. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat. Med. 13:543.
206. Napirei, M., Karsunky, H., Zevnik, B., Stephan, H., Mannherz, H. G. and Möröy, T. 2000. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat. Genet. 25:177.
207. Yasutomo, K., Horiuchi, T., Kagami, S. et al. 2001. Mutation of DNASE1 in people with systemic lupus erythematosus. Nat. Genet. 28:313.
208. Okabe, Y., Kawane, K., Akira, S., Taniguchi, T. and Nagata, S. 2005. Toll-like receptor-independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation. J. Exp. Med. 202:1333.
209. Yoshida, H., Okabe, Y., Kawane, K., Fukuyama, H. and Nagata, S. 2005. Lethal anemia caused by interferon-beta produced in mouse embryos carrying undigested DNA. Nat. Immunol. 6:49.
210. Kawane, K., Ohtani, M., Miwa, K. et al. 2006. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 443:998.
211. Zheng, L., Dai, H., Zhou, M. et al. 2007. Fen1 mutations result in autoimmunity, chronic inflammation and cancers. Nat. Med. 13:812.
212. Crow, Y. J., Hayward, B. E., Parmar, R. et al. 2006. Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus. Nat. Genet. 38:917.
213. Lee-Kirsch, M. A., Gong, M., Chowdhury, D. et al. 2007. Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat. Genet. 39:1065.
214. Stetson, D. B., Ko, J. S., Heidmann, T. and Medzhitov, R. 2008. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134:587.
215. Lande, R., Gregorio, J., Facchinetti, V. et al. 2007. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449:564.
216. Means, T. K., Latz, E., Hayashi, F., Murali, M. R., Golenbock, D. T. and Luster, A. D. 2005. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Invest. 115:407.
217. Tian, J., Avalos, A. M., Mao, S. Y. et al. 2007. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 8:487.
218. Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Shlomchik, M. J. and Marshak-Rothstein, A. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416:603.
219. Matsumoto, F., Saitoh, S., Fukui, R. et al. 2008. Cathepsins are required for Toll-like receptor 9 responses. Biochem. Biophys. Res. Commun. 367:693.
220. Asagiri, M., Hirai, T., Kunigami, T. et al. 2008. Cathepsin K-dependent toll-like receptor 9 signaling revealed in experimental arthritis. Science 319:624.
221. Vollmer, J., Tluk, S., Schmitz, C. et al. 2005. Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J. Exp. Med. 202:1575.
222. Lau, C. M., Broughton, C., Tabor, A. S. et al. 2005. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J. Exp. Med. 202:1171.
223. Pisitkun, P., Deane, J. A., Difilippantonio, M. J., Tarasenko, T., Satterthwaite, A. B. and Bolland, S. 2006. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312:1669.
224. Deane, J. A., Pisitkun, P., Barrett, R. S. et al. 2007. Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 27:801.
225. Malathi, K., Dong, B., Gale, M. J. and Silverman, R. H. 2007. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448:816.
226. McDermott, M. F. and Tschopp, J. 2007. From inflammasomes to fevers, crystals and hypertension: How basic research explains inflammatory diseases. Trends Mol. Med. 13:381.
227. Bustamante, J., Boisson-Dupuis, S., Jouanguy, E. et al. 2008. Novel primary immunodeficiencies revealed by the investigation of paediatric infectious diseases. Curr. Opin. Immunol. 20:39.
228. Smyth, D. J., Cooper, J. D., Bailey, R. et al. 2006. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat. Genet. 38:617.
229. Graham, R. R., Kozyrev, S. V., Baechler, E. C. et al. 2006. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat. Genet. 38:550.
230. von Bernuth, H., Picard, C., Jin, Z. et al. 2008. Pyogenic bacterial infections in humans with MyD88 deficiency. Science 321:691.